Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05945784 · ClinicalTrials.gov registry record
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
A clinical trial, sponsored by Casa Colina Hospital and Centers for Healthcare.
- Completed
- Registry status
- 57
- Enrollment target
NCT05945784: Completed study, sponsored by Casa Colina Hospital and Centers for Healthcare.
NCT05945784 is a clinical trial that has completed, run by Casa Colina Hospital and Centers for Healthcare. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05945784 has completed, sponsored by Casa Colina Hospital and Centers for Healthcare.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.
Primary Outcome
It is a validated self-reported instrument to assess packaging of the makeup. A few questions will focus on shape of the cap, length of the wand, shape of the doe foot, finish of the components, how it affects grip, and weight of the component/applicator. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).
Interventions
- OTHER Use of Rare Beauty makeup products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-07-21 |
| Est. Completion | 2023-09-29 |
What the finished NCT05945784 record still lists
NCT05945784 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Use of Rare Beauty makeup products is the first listed.
NCT05945784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05945784 about?
NCT05945784 is a clinical study titled "Exploring Accessible Beauty for Individuals With Upper Extremity Deficits". The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper ext...
What is the current status of trial NCT05945784?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2023-07-21. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT05945784?
The interventions under investigation include: Use of Rare Beauty makeup products (OTHER).
Who is sponsoring clinical trial NCT05945784?
This trial is sponsored by Casa Colina Hospital and Centers for Healthcare, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI